Search

Jewn G Park

from Fairfax, VA
Age ~65
Get Report
Also known as:
Jewn Giew dr Park, Stephen Park, Jerome Giew Park, Jewn Park, Jewngiew Park, Jerome Park, Ork O Jewn, W Park, Jewn Giew Park
10721 Marlborough Rd, Fairfax, VA 22032
Related to:
Seung W ParkGloria O Park, 61Chan W Park, 37Seungwoo W Park, 60Jhoo H Park, 34Sung D Park, 60
Connected to:
Adam H Park, 43Ae R Park, 58Alena Park, 31Alison J Park, 50Allie Park, 28Alysia Park, 40Amelia Park, 40Andrew E Park, 38Anthony M Park, 42Augustine S Park, 49

Jewn Park Phones & Addresses

  • 10721 Marlborough Rd, Fairfax, VA 22032
  • Arlington, VA
  • Apple Valley, MN
  • Rochester, MN
  • Cleveland, OH
  • Manhattan, KS
  • Lawrence, KS
  • 2212 Hampton Rhodes Ct NW, Rochester, MN 55901 (507) 287-0042

Emails

a***[email protected]

Publications

Us Patents

Efficient Methods For Solid Phase Synthesis Using Trityl Chloride Resins

View page
US Patent:
7427260, Sep 23, 2008
Filed:
Mar 29, 2002
Appl. No.:
10/472708
Inventors:
Yuan-Ping Pang - Rochester MN, US
Jewn Giew Park - Rochester MN, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C40B 50/14
US Classification:
506 30, 528422, 564305
Abstract:
Disclosed are efficient methods for loading amino derivatives onto trityl chloride resins and for cleaving chemically modified amino derivatives from trityl chloride resins. Methods for making a library of discrete chemically modified amino derivatives also disclosed.

Small-Molecule Botulinum Toxin Inhibitors

View page
US Patent:
8404728, Mar 26, 2013
Filed:
Jul 29, 2010
Appl. No.:
12/846187
Inventors:
Yuan-Ping Pang - Rochester MN, US
Jewn Giew Park - Rochester MN, US
Shaohua Wang - Rochester MN, US
Anuradha Vummenthala - Iowa City IA, US
Rajesh K Mishra - Iowa City IA, US
Jon Davis - Silver Spring MD, US
Charles B. Millard - Frederick MD, US
James J. Schmidt - Mt. Airy MD, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
U.S. Army Medical Research and Material Command - Washington DC
International Classification:
A01N 43/78
A01N 43/80
A01N 43/76
A01N 43/50
A01N 43/56
A61K 31/425
A61K 31/42
A61K 31/415
C07D 271/00
C07D 285/02
C07D 285/04
C07D 417/00
C07D 513/00
C07D 277/20
C07D 275/02
C07D 263/30
C07D 413/00
C07D 261/06
C07D 257/04
C07D 257/10
C07D 403/00
C07D 487/00
C07D 249/04
C07D 249/08
C07D 233/61
C07D 231/00
C07D 207/00
US Classification:
514365, 514372, 514374, 514378, 514396, 514403, 548125, 548202, 548214, 548235, 548254, 548255, 5482672, 5483355, 5483751, 548566, 548247
Abstract:
This disclosure relates to materials and methods for inhibiting Botulinum neurotoxin, and more particularly to materials and methods for inhibiting the zinc endopeptidase of Botulinum neurotoxin serotypes A, D and/or E (BoNTA, BoNTD and/or BoNTE).

Small-Molecule Botulinum Toxin Inhibitors

View page
US Patent:
8492428, Jul 23, 2013
Filed:
Sep 20, 2006
Appl. No.:
12/067158
Inventors:
Yuan-Ping Pang - Rochester MN, US
Jewn Giew Park - Rochester MN, US
Jing Tang - Rochester MN, US
Charles B. Millard - Frederick MD, US
James J. Schmidt - Mt. Airy MD, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
The United States of America As Represented by the Secretary of the Army - Washington DC
International Classification:
A61K 31/404
C07D 209/08
C07D 401/14
C07D 403/14
US Classification:
514414, 544333, 5462774, 548468
Abstract:
Small-molecule inhibitors of Botulinum toxin, including BoNTA, BoNTD and BoNTE are provided, as well as methods of using the inhibitors.

Antiviral Compositions And Methods

View page
US Patent:
20070149487, Jun 28, 2007
Filed:
Nov 7, 2006
Appl. No.:
11/557396
Inventors:
Yuan-Ping Pang - Rochester MN, US
Andrea Dooley - Saint Cloud MN, US
Jewn Park - Rochester MN, US
Assignee:
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH - Rochester MN
International Classification:
A61K 31/655
A61K 31/47
A61K 31/403
A61K 31/381
A61K 31/343
US Classification:
514150000, 514311000, 514411000, 514443000, 514468000
Abstract:
Compositions and methods for treating, preventing, or ameliorating one or more symptoms, conditions, or disorders associated with coronavirus infections are provided, in particular small-molecule inhibitors of the chymotrypsin-like cysteine protease of SARS CoV.

Selective Inhibitors Of C-Jun N-Terminal Kinase

View page
US Patent:
20110269810, Nov 3, 2011
Filed:
Apr 4, 2011
Appl. No.:
13/079254
Inventors:
Yuan-Ping Pang - Rochester MN, US
Anuradha Vummenthala - Iowa City IA, US
Jewn Giew Park - Rochester MN, US
Shao-Hua Wang - Rochester MN, US
Zigang Dong - Rochester MN, US
Ann M. Bode - Cannon Falls MN, US
Yong Yeon Cho - Rochester MN, US
Assignee:
Regents of the University of Minnesota - Saint Paul MN
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
A61K 31/403
A61P 19/02
A61P 3/10
A61P 25/28
C07D 209/56
C12N 9/99
US Classification:
514410, 548420, 435184
Abstract:
Compositions and methods for treating, preventing, or ameliorating one or more symptoms, disorders, or conditions associated with particular c-Jun N-terminal kinase(s) (JNKs) activity are provided. Compositions contain small molecules such as pyrazoloanthrones.
Control profile
Jewn G Park from Fairfax, VA, age ~65 Get Report